Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Esophageal Neoplasms × capivasertib × Clear all

Sponsor

Conditions

Triple Negative Breast Neoplasms 2 Recurrence 1 Neoplasms 1 Multiple Myeloma 1 Lymphoma, Mantle-Cell 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, B-Cell 1 Lymphoma 1 Locally Advanced (Inoperable) or Metastatic Breast Cancer 1 Hematologic Neoplasms 1 Carcinosarcoma 1 Carcinoma, Endometrioid 1 Breast Neoplasms 1 Advanced Solid Malignancy, 1

Interventions

Fluorouracil 34 Cisplatin 34 Radiotherapy 30 Oxaliplatin 30 Paclitaxel 22 pembrolizumab 20 Irinotecan 20 Docetaxel 20 Leucovorin 19 Capecitabine 16 Cetuximab 11 Carboplatin 11 Bevacizumab 11 Surgical Procedures, Operative 9 Radiation 9 Trastuzumab 8 Panitumumab 6 Epirubicin 6 Neoadjuvant Therapy 5 Esophagectomy 4 Erlotinib Hydrochloride 4 Chemotherapy, Adjuvant 4 tisotumab vedotin 3 durvalumab 3 Sunitinib 3 Microarray Analysis 3 Immunohistochemistry 3 Gene Expression Profiling 3 Gemcitabine 3 Albumin-Bound Paclitaxel 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡